GBY Analysis

Sangamo Therapeutics, Inc.
Stock Exchange: XETRA
Sector: biotechnology
5.266
Last session price
5.266
Price now
Currency: EUR
Reporting currency: USD
ISIN: US8006771062
INN:
.

GBY financial statements

* Numbers in thousands
Capitalization * 590 392
EV * 1 198 445
Number of shares * 112 114
EPS -1,08
Revenue * 118 192
Net income * -120 996
Operating profit * -129 552
Total liabilities * 441 184
Net debt * -89 243
Total assets * 938 550
Equity * 498 234
Cash and investments * 641 423
.

GBY valuation

P/E -4,88
P/B 1,18
P/S 5,00
E/P -20
P/FCF 3,81
.

GBY profitability

ROE -24%
ROA% -14%
ROIC% -16%